
### [NCIT:C136619](http://purl.obolibrary.org/obo/NCIT_C136619)
**Label:** Stage III Bone Cancer AJCC v8

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C27970](http://purl.obolibrary.org/obo/NCIT_C27970) (Stage III) 57.14%
- [NCIT:C132248](http://purl.obolibrary.org/obo/NCIT_C132248) (AJCC v8 Stage) 57.14%
- Thing 52.12%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 42.50%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 42.50%


